MiniMed Group, Inc. reported $3.22B of revenue over the trailing twelve months. 6 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $3.22B (to Q1 2027). Net income: −$309M, trailing twelve months to Q1 2027. Operating margin: −5.3%, trailing twelve months to Q1 2027. EPS: −$1.22, trailing twelve months to Q1 2027.

MMEDMiniMed Group, Inc.

Healthcare

$19.73

$10.8052 weeks$23.83

MMED as reported

MiniMed Group, Inc. reported $3.22B of revenue over the trailing twelve months. 6 reported series are charted on this page, each one as filed.

$3.22B

Revenue, trailing twelve months · to Q1 2027 · every figure below is as filed, with no scoring applied

Net income: −$309M
Net income · trailing twelve months to Q1 2027
Operating margin: −5.3%
Operating margin · trailing twelve months to Q1 2027
EPS: −$1.22
EPS · trailing twelve months to Q1 2027

Details›

Every series Ryufin has for MMED, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$3.22B	n/a	Q1 2027
Net income	−$309M	n/a	Q1 2027
EPS	−$1.22	n/a	Q1 2027
Gross margin	54%	n/a	Q1 2027
Operating margin	−5.3%	n/a	Q1 2027
Net margin	−9.5%	n/a	Q1 2027

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.